Key statistics
On Tuesday, Mainz Biomed NV (MYNZ:NAQ) closed at 0.3929, 28.40% above the 52 week low of 0.306 set on Aug 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.355 |
---|---|
High | 0.408 |
Low | 0.351 |
Bid | 0.3847 |
Offer | 0.392 |
Previous close | 0.3537 |
Average volume | 1.63m |
---|---|
Shares outstanding | 21.89m |
Free float | 17.15m |
P/E (TTM) | -- |
Market cap | 7.74m USD |
EPS (TTM) | -1.67 USD |
Data delayed at least 15 minutes, as of Sep 03 2024 21:00 BST.
More ▼
- Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
- Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
- Mainz Biomed Provides Half Year 2024 Corporate Update
- Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
- Mainz Biomed Reports Results of 2024 Annual General Meeting
- Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
- Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
- Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
- Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
- Mainz Biomed Reports Full Year 2023 Financial Results
More ▼